Clinical feasibility and impact of fully automated multiparametric PET imaging using direct Patlak reconstruction: evaluation of 103 dynamic whole-body 18F-FDG PET/CT scans-Reference-Cited by-同舟云学术

Clinical feasibility and impact of fully automated multiparametric PET imaging using direct Patlak reconstruction: evaluation of 103 dynamic whole-body 18F-FDG PET/CT scans

Published:2020-09-07 Issue:3 Volume:48 Page:837-850
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Dias André H.^ORCID,Pedersen Mette F.,Danielsen Helle,Munk Ole L.^ORCID,Gormsen Lars C.^ORCID

Funder

Novo Nordisk Fonden

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00259-020-05007-2.pdf

Reference27 articles.

1. Juweid ME, Cheson BD. Positron-emission tomography and assessment of cancer therapy. N Engl J Med. 2006;354:496–507. https://doi.org/10.1056/NEJMra050276.

2. Weber WA. Positron emission tomography as an imaging biomarker. J Clin Oncol. 2006;24:3282–92. https://doi.org/10.1200/jco.2006.06.6068.

3. Weber WA, Wieder H. Monitoring chemotherapy and radiotherapy of solid tumors. Eur J Nucl Med Mol Imaging. 2006;33(Suppl 1):27–37. https://doi.org/10.1007/s00259-006-0133-3.

4. Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–54. https://doi.org/10.1007/s00259-014-2961-x.

5. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(Suppl 1):122s–50s. https://doi.org/10.2967/jnumed.108.057307.

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of different parametric Patlak imaging approaches and comparison with a 2-tissue compartment pharmacokinetic model with a long axial field-of-view (LAFOV) PET/CT in oncological patients;European Journal of Nuclear Medicine and Molecular Imaging;2024-09-11

2. Whole-Body Multiparametric PET in Clinical Oncology: Current Status, Challenges, and Opportunities;American Journal of Roentgenology;2024-09-04

3. Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends;Seminars in Nuclear Medicine;2024-09

4. Application of Dynamic [18F]FDG PET/CT Multiparametric Imaging Leads to an Improved Differentiation of Benign and Malignant Lung Lesions;Molecular Imaging and Biology;2024-08-22

5. Glucose metabolic rate from four-dimensional [18F]FDG PET/CT to differentiate sarcoid lesions from malignant lesions;European Radiology;2024-08-16